Hepatitis C Hepatitis C  As of 2012, the U. S.  Centers for Disease Control and Prevention  recommends a single screening test for those born between 1945 and 1965.  In Canada, a one-time screening is recommended for those born between 1945 and 1975. As of 2022, no approved vaccine protects against contracting hepatitis C.  A combination of harm reduction strategies, such as the provision of new needles and syringes and treatment of substance use, decreases the risk of hepatitis C in people using injection drugs by about 75%.  The screening of blood donors is important at a national level, as is adhering to universal precautions within healthcare facilities Hepatitis C Hepatitis C